Professor

Jian Li

FAA

Jian Li
Image Description
Jian Li is an international authority in antimicrobial discovery and development. He has led multiple impactful research programs to combat life-threatening bacterial ‘superbugs’. His internationally recognised systematic pharmacology research has resulted in the development of a novel antibiotic drug from concept to clinical trials. His research has also led to the first dosing guidelines for the last-defence polymyxin antibiotics and significantly improved clinical anti-microbial practice globally. Li has shown outstanding strategic leadership in building strong university-industry-hospital linkages and held multiple leadership positions in international societies. He is a passionate advocate for commercialisation and clinical translation of biomedical discoveries.

Fields of research

31 BIOLOGICAL SCIENCES
  • 3101 BIOCHEMISTRY AND CELL BIOLOGY
    • 310114 Systems Biology
32 BIOMEDICAL AND CLINICAL SCIENCES
  • 3207 MEDICAL MICROBIOLOGY
    • 320799 Medical Microbiology not elsewhere classified
  • 3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES
    • 321402 Clinical Pharmacology and Therapeutics
    • 321407 Toxicology (incl. Clinical Toxicology)
    • 321499 Pharmacology and Pharmaceutical Sciences not elsewhere classified

For full list of research codes, please visit the ARC Website .

Expertise type

  • Antibiotic Resistance
  • Drug Design
  • Clinical Translation
  • Pseudomonas
  • Antibacterial Discovery
  • Pharmacology
  • Drug Discovery
  • Bacterial Pathogens
  • Drug Mechanisms
  • Infectious Diseases
  • Microbiology
  • Biofilms
  • Drug Delivery
  • Pharmaceutical Sciences
  • Pharmacokinetics
  • Biology

Please contact fellowship@science.org.au to request any updates to the data.